Share this article
Share this article
AUSTIN, Texas, Jan. 28, 2021 /PRNewswire/ VolitionRx Limited (NYSE AMERICAN: VNRX) ( Volition ), a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help diagnose a range of cancers and other diseases in both humans and animals, has an abstract presented today at the world s largest lung cancer meeting, the WCLC, which is being held virtually this year.
Watch a short interview where Chief Scientific Officer, Dr. Jake Micallef discusses the results - https://youtu.be/QbC7eJKw3pQ
Watch a short interview where Chief Scientific Officer, Dr. Jake Micallef discusses the results - https://youtu.be/QbC7eJKw3pQ